Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 952-957

  Visvanathan, Sudha ^a   Keenan, Gregory F ^b   Baker, Daniel G ^c   Levinson, Arnold I ^d   Wagner, Carrie L ^a,c  

^a Clinical Pharmacology and Experimental Medicine   (United States)

^b Medical Affairs   (United States)

^c CENTOCOR INC   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Infliximab; Pneumococcal vaccine; Rheumatoid arthritis; Tumor necrosis factor inhibitors

Indexed keywords

INFLIXIMAB; METHOTREXATE; PNEUMOCOCCUS VACCINE;

ADULT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROTYPE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 34248643414     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Elkayam O, Paran D, Caspi D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mort Wkly Rep 1997;46 (RR-80):1-24.
3. Whitney CG. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age ≥ 65. Geriatrics 2003;58:20-2, 25.
4. DeFranco AL. B-lymphocyte activation. In: Paul WE, editor. Fundamental immunology. Philadelphia: Lippincott-Raven; 1999:225-61.
5. Pirofski L, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998;11:1-26.
6. Simberkoff MS, Cross AP, Al-Ibraham M, et al. Efficacy of pneumococcal vaccine in high risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318-27.
7. Mease P, Ritchlin C, Martin R, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-61.
8. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites DP, Abba IT, editors. Basic and clinical immunology. Norwalk, CT: Appleton and Lange; 1991:78-100.
9. St. Clair EW, van der Heijde DMFM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. Arthritis Rheum 2004;50:3432-43.
10. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology Oxford 2006;45:106-11.
11. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers. Ann Rheum Dis 2006;65:191-4.
12. Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8.
13. Mufson MA. Antibody response of pneumococcal vaccine: need for booster dosing? Int J Antimicrob Agents 2000;14:107-12.
14. World Health Organization. Pneumococcal vaccines: World Health Organization position paper. Can Commun Dis Rep 1999;25:150-1.
15. Rubins JB, Puri AK, Loch J, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998;178:431-40.
16. Kaine J, Kivitz A, Birbara C, Luo AY. Effect of adalimumab (Humira®) on response to pneumococcal and influenza virus vaccines in patients with rheumatoid arthritis (RA). Ann Rheum Dis 2006;65 Suppl II:304.